SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017182
Filing Date
2019-05-08
Accepted
2019-05-08 16:06:28
Documents
75
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20190331.htm 10-Q 1885109
2 EX-31.1 flxn-ex311_8.htm EX-31.1 10026
3 EX-31.2 flxn-ex312_7.htm EX-31.2 10111
4 EX-32.1 flxn-ex321_6.htm EX-32.1 9110
  Complete submission text file 0001564590-19-017182.txt   7395203

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flxn-20190331.xml EX-101.INS 1658158
6 XBRL TAXONOMY EXTENSION SCHEMA flxn-20190331.xsd EX-101.SCH 55668
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20190331_cal.xml EX-101.CAL 60868
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20190331_def.xml EX-101.DEF 169313
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20190331_lab.xml EX-101.LAB 445567
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20190331_pre.xml EX-101.PRE 334168
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 19806640
SIC: 2834 Pharmaceutical Preparations